Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients

TerminatedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

November 18, 2015

Primary Completion Date

July 31, 2020

Study Completion Date

December 31, 2020

Conditions
Amputation WoundPeripheral Arterial Disease
Interventions
DEVICE

SpectralMD DeepView Wound Imaging System 2.0

The DeepView is an imaging device which simultaneously performs multispectral imaging (MSI) measurements across the visible and infrared spectrum to obtain a quantitative tissue viability assessment. These optical measurements are integrated using a machine learning (ML) algorithm to categorize microvascular blood flow and provide a quantitative assessment for selection of tissue healing.

Trial Locations (1)

75093

Dr. Dennis Gable, Plano

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Baylor Research Institute

OTHER

lead

SpectralMD

INDUSTRY

NCT03611361 - Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients | Biotech Hunter | Biotech Hunter